WELLS FARGO & COMPANY/MN - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$43,695,000
+32.3%
223,287
+14.9%
0.01%
+20.0%
Q2 2020$33,028,000
+110.4%
194,367
+42.9%
0.01%
+100.0%
Q1 2020$15,695,000
-12.8%
136,028
-13.7%
0.01%0.0%
Q4 2019$18,003,000
+101.7%
157,564
+50.8%
0.01%
+66.7%
Q3 2019$8,925,000
+29.0%
104,513
+4.5%
0.00%
+50.0%
Q2 2019$6,919,000
-10.4%
99,979
-5.2%
0.00%0.0%
Q1 2019$7,723,000
+31.2%
105,444
+1.5%
0.00%0.0%
Q4 2018$5,887,000
-75.1%
103,911
-66.1%
0.00%
-71.4%
Q3 2018$23,647,000
+10.0%
306,619
-5.3%
0.01%
+16.7%
Q2 2018$21,500,000
+33.9%
323,857
+5.6%
0.01%
+20.0%
Q1 2018$16,051,000
+327.7%
306,681
+337.2%
0.01%
+400.0%
Q4 2017$3,753,000
+49.8%
70,143
+52.3%
0.00%0.0%
Q3 2017$2,506,000
-81.9%
46,069
-82.8%
0.00%
-75.0%
Q2 2017$13,865,000
-31.5%
267,976
-16.7%
0.00%
-42.9%
Q1 2017$20,228,000
+370.9%
321,791
+295.3%
0.01%
+250.0%
Q4 2016$4,296,000
+6.9%
81,409
+9.4%
0.00%
+100.0%
Q3 2016$4,018,000
+33.1%
74,396
-0.4%
0.00%0.0%
Q2 2016$3,018,000
-27.0%
74,708
-36.6%
0.00%
-50.0%
Q1 2016$4,137,000
-22.5%
117,912
-0.8%
0.00%0.0%
Q4 2015$5,336,000
+5.1%
118,885
-9.7%
0.00%0.0%
Q3 2015$5,076,000
-33.6%
131,658
-16.6%
0.00%
-33.3%
Q2 2015$7,640,000
-30.1%
157,828
-48.9%
0.00%
+50.0%
Q1 2015$10,924,000
+98.6%
309,084
+80.5%
0.00%0.0%
Q4 2014$5,501,000
-11.7%
171,223
+2.1%
0.00%
-33.3%
Q3 2014$6,233,000
+5.0%
167,631
+8.0%
0.00%
+50.0%
Q2 2014$5,938,000
-21.1%
155,214
-6.0%
0.00%
-33.3%
Q1 2014$7,522,000
-31.7%
165,098
-40.2%
0.00%
-40.0%
Q4 2013$11,019,000
+1.1%
276,208
+11.1%
0.01%0.0%
Q3 2013$10,896,000
+28.1%
248,571
-8.0%
0.01%
+25.0%
Q2 2013$8,504,000270,3220.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 57,170$10,013,0005.39%
Boxer Capital, LLC 400,000$70,056,0002.25%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 110,153$19,292,0001.10%
DCF Advisers, LLC 13,300$2,329,0000.96%
XTX MARKETS LLC 2,418$423,0000.87%
FAIRFIELD, BUSH & CO. 15,035$2,633,0000.77%
Parcion Private Wealth LLC 4,520$792,0000.10%
Gulf International Bank (UK) Ltd 26,091$4,569,0000.06%
Princeton Portfolio Strategies Group LLC 1,500$263,0000.05%
Redpoint Investment Management Pty Ltd 2,392$419,0000.04%
View complete list of SEATTLE GENETICS INC shareholders